| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |